Published in Semin Hematol on July 01, 1974
Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes. J Exp Med (1975) 4.96
Hodgkin's disease. An immunodepleting and immunosuppressive disorder. J Clin Invest (1975) 2.44
Genetic associations between myasthenia gravis and the HL-A system. J Neurol Neurosurg Psychiatry (1976) 1.08
Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants. Nature (1976) 4.83
Influence of non-inherited maternal HLA antigens on occurrence of rheumatoid arthritis. Lancet (1993) 3.87
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci U S A (1981) 2.86
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Y-antigen killing by T cells of women is restricted by HLA. Nature (1977) 2.73
Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant Proc (1971) 2.63
Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation. N Engl J Med (1996) 2.63
HLA-linked genetic control of host response to Mycobacterium leprae. Lancet (1976) 2.45
Induction of B cell unresponsiveness to noninherited maternal HLA antigens during fetal life. Science (1988) 2.28
The major histocompatibility complex--genetics and biology. (First of three parts). N Engl J Med (1976) 1.92
Lymphocyte antibody lymphocytolytic interaction (LALI) with special emphasis on HL-A. Transplant Proc (1973) 1.75
HLA-DR phenotypes in Spanish coeliac children: their contribution to the understanding of the genetics of the disease. Gut (1983) 1.65
T90/44 (9.3 antigen). A cell surface molecule with a function in human T cell activation. Eur J Immunol (1986) 1.62
Genetic basis of gluten-sentitive enteropathy. Gastroenterology (1978) 1.60
The serological recognition of the human MLC determinants using a modified cytotoxicity technique. Tissue Antigens (1975) 1.54
Stability of HL-A and appearance of other antigens (LIVA) at the surface of lymphoblasts grown in vitro. Haematologica (1969) 1.53
Possible implications of the effect of blood transfusion on allograft survival. Lancet (1983) 1.46
In vitro immune responsiveness to vaccinea virus and HLA. N Engl J Med (1977) 1.43
The relative radioresistance of interleukin-2 production by human peripheral blood lymphocytes: consequences for the development of a new limiting dilution assay for the enumeration of helper T lymphocyte precursor frequencies. J Immunol Methods (1994) 1.43
Anti HL-A2 inhibitor in normal human serum. Nature (1970) 1.40
Mitochondrial DNA polymorphism in four Sardinian villages. Ann Hum Genet (1988) 1.39
Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients. Diabetes (1999) 1.38
Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet (1977) 1.37
A minor transplantation antigen detected by MHC-restricted cytotoxic T lymphocytes during graft-versus-host disease. Nature (1983) 1.34
Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. Ann Rheum Dis (1984) 1.33
Mixed lymphocyte culture and HL-A. Transplant Proc (1972) 1.33
Murine monoclonal antibodies against HLA structures. Immunol Rev (1979) 1.31
HLA-DR-associated genetic control of the type of leprosy in a population from surinam. Hum Immunol (1982) 1.30
Lymphocyte transformation in vitro. II. Mixed lymphocyte culture in relation to leucocyte antigens. Clin Exp Immunol (1970) 1.28
Genetic control of survival in epidemics. J Immunogenet (1979) 1.28
HLA-linked control of predisposition to lepromatous leprosy. J Infect Dis (1985) 1.28
The major histocompatibility complex - genetics and biology (third of three parts). N Engl J Med (1976) 1.28
Typing for MLC (LD). II. The selection of nonstimulator cells by MLC inhibition tests using SD-indentical stimulator cells (MISIS) and fluorescence antibody studies. Transplant Proc (1973) 1.26
Efficacy of HL-A matching in Eurotransplant. Lancet (1972) 1.25
Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients. Cancer (1987) 1.25
Cell-mediated lympholysis studies in renal allograft recipients. Transplantation (1981) 1.25
Alloimmunity to human H-Y. Lancet (1976) 1.20
Rejection of bone-marrow graft by recipient-derived cytotoxic T lymphocytes against minor histocompatibility antigens. Lancet (1990) 1.19
Effect of HLA-A and HLA-B matching on survival of grafts and recipients after renal transplantation. N Engl J Med (1982) 1.18
IgM-IgG cryoglobulinaemia with IgM paraprotein component. Clin Exp Immunol (1968) 1.15
Experimental allotransplantation in man. I. The role of the HL-A system in different genetic combinations. Transplant Proc (1969) 1.15
Structural heterogeneity of C2 Complement protein and its genetic variants in man: a new polymorphism of the HLA region. Proc Natl Acad Sci U S A (1977) 1.14
Platelet and granulocyte specific allo-antigens in chimpanzees. Tissue Antigens (1983) 1.14
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Letter: HL-A 27 and ankylosing spondylitis. Lancet (1975) 1.13
Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12
How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more! Bone Marrow Transplant (2005) 1.11
Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci U S A (2001) 1.11
Immunogenetics of human minor histocompatibility antigens: their polymorphism and immunodominance. Immunogenetics (1992) 1.10
Graft survival in unrelated donor--recipient pairs matched for MLC and HL-A. Transplant Proc (1973) 1.09
Serological and molecular studies of Epstein-Barr virus infection in allogeneic marrow graft recipients. Transplantation (1990) 1.09
Cell mediated lympholysis in man after sensitization of effector lymphocytes through mixed leukocyte cultures. G Batteriol Virol Immunol (1973) 1.09
Cadaveric graft survival, clinical course, blood transfusion, HLA (A and B) match, and DR match in adult patients transplanted in one centre. Proc Eur Dial Transplant Assoc (1979) 1.07
In vitro sensitivity to prednisolone may predict kidney rejection after steroid withdrawal. Transplantation (1996) 1.07
HL-A identical phenotypes and genotypes in unrelated individuals. Lancet (1970) 1.07
[Position of a locus determining mixed lymphocyte reaction distinct from the known HL-A loci]. Eur J Immunol (1972) 1.06
Joint report of 1st International Workshop on Canine Immunogenetics. Tissue Antigens (1973) 1.06
Leukocyte typing and kidney transplantation in unrelated donor-recipient pairs. A study in patients of Drs. S. Peart, J.F.Mowbray, and G.R.J. Alexandre. Transplant Proc (1969) 1.06
Evidence for two series of B-cell antigens in man and their comparison with HLA-D. Scand J Immunol (1977) 1.05
Influence of a single blood transfusion on kidney allograft survival in unrelated rhesus monkeys. Transplantation (1978) 1.04
The quest for a bone marrow donor--optimal or maximal HLA matching? N Engl J Med (1998) 1.04
Cell-mediated lympholysis in vitro with normal lymphocytes as target: specificity and cross-reactivity of the test. Transplant Proc (1972) 1.03
The importance of H-Y incompatibility in human organ transplantation. Transplantation (1978) 1.03
B-cell antibodies, Ia-like determinants, and their relation to MLC determinants in man. Transplant Rev (1976) 1.02
Mapping SB in relation to HLA and GLO1 using cells from first-cousin marriage offspring. Immunogenetics (1983) 1.01
Interaction of penicillin with HLA-A and -B antigens. Hum Immunol (1982) 1.01
HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML). Tissue Antigens (1976) 1.01
Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3. Clin Exp Immunol (1984) 1.01
HLA antigen distribution and HLA haplotype segregation in Crohn's disease. Tissue Antigens (1980) 1.01
Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med (1989) 1.01
Major histocompatibility complex-restricted antibody reactivity mainly, but not exclusively, directed against cells from male donors. J Exp Med (1979) 0.99
HLA-linked lymphocyte activating determinants. Immunol Rev (1982) 0.99
Fate of HL-A antigens and antibodies at the lymphocyte surface. Transplant Proc (1973) 0.99
Distribution of endothelial-monocyte and HLA antigens on renal vascular endothelium. Transplant Proc (1981) 0.98
Detection of platelet antibodies by enzyme-linked immunosorbent assay (ELISA) on artificial monolayers of platelets. Immunol Lett (1981) 0.97
Failure of lymphocyte-membrane HLA-A and -B expression in two siblings with combined immunodeficiency. Clin Immunol Immunopathol (1979) 0.97
Mixed lymphocyte cultures and HL-A. Transplant Proc (1971) 0.96
HLA-linked control of the course of M. leprae infections. Lepr Rev (1981) 0.96
Mixed-lymphocyte-culture and skin-graft data in unrelated HL-A identical individuals. Lancet (1971) 0.96
HLA-DO polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med (1986) 0.96
Clinical experience with bone marrow transplantation: failure and success. Transplant Proc (1971) 0.96
HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis (1980) 0.96
Antibodies directed against antigens on the endothelium of peritubular capillaries in patients with rejecting renal allografts. Transplantation (1979) 0.95
DR typing in Australian Aborigines. An indication for a second locus in the HLA--D region defined by serology. Tissue Antigens (1980) 0.94
Matching for HLA antigens of A, B, and DR loci in renal transplantation by Eurotransplant. Lancet (1978) 0.94
Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept. Lancet (1996) 0.93
Separation of human cells bearing HLA-DR antigens using a monoclonal antibody rosetting method. Tissue Antigens (1979) 0.93
Hla, and the response to treatment with gamma-type endorphins in schizophrenia. J Immunogenet (1982) 0.93
Renal transplant patients monitored by the cell-mediated lympholysis assay. Evaluation of its clinical value. Transplantation (1989) 0.93
Mixed leukocyte cultures and HL-A antigens. II. Inhibition by anti-HL-A sera. Transplant Proc (1971) 0.92
Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor. Transplantation (1973) 0.92
Polymorphic and monomorphic HLA-DR determinants on human hematopoietic progenitor cells. Blood (1984) 0.92
Typing for MLC (LD). I. Lymphocytes from cousin-marriage offspring as typing cells. Transplant Proc (1973) 0.92
The effect of HLA matching on kidney graft survival in separate posttransplantation intervals. Transplantation (1990) 0.92
New facts on HLA genetics: are they relevant in bone marrow transplantation? Semin Hematol (1984) 0.92
Validation of haplotype frequency estimation methods. Hum Immunol (1998) 0.91
Quantitative analysis of cell surface HLA structures by means of monoclonal antibodies. Hum Immunol (1980) 0.91
Retrospective and prospective studies on the effect of blood transfusions in renal transplantation in The Netherlands. Transplantation (1979) 0.91
Bone Marrow Donors Worldwide: a successful exercise in international cooperation. Bone Marrow Transplant (1994) 0.91